Impact of NLEM 2015 on Pharmaceutical industry

1. IMPACT OF NLEM-2015 ON
PHARMACEUTICAL
INDUSTRY
PRESENTED BY:
AMAN DUBE (QA-04)
RIDDHI DESAI(QA-03)
RUQAIYA VASI (QA-17)
IAN FERNANDIS (QA-20)
KANJANI SHAH(QA-15)

2. NLEM 2015
The health ministry has revised its
National List of Essential Medicines
(NLEM) to include 376 drugs in the
new NLEM 2015 list.
While a total of 106 medicines have
been added, 70 medicines have been
deleted to finalize the new list.

3. VALUE LOST ON INCREMENTAL PRICES CAPPED AS
PER REVISED NLEM LIST

4. VOLUME GROWTH TRENDS

5. PRICING GROWTH TRENDS

6. EFFECT ON THERAPEUTIC CATEGORIES

7. CIPLA SALES GROWTH TRENDS

8. Source: IMS

9. 1
24%
2
17%
3
22%
4
19%
5
18%
ABACAVIR
1
2
3
4
5
1 = 2011
2 = 2012
3 =2013
4 = 2014
5 = 2015
Source : IMS
1
12%
2
17%
3
20%
4
25%
5
26%
TENOFOVIR
1
2
3
4
5

10. REVENUE CONTRIBUTION OF MOLECULES OF CIPLA
Source: IMS

11. Source : IMS
ANTICANCER DRUGS
INCLUDED IN NLEM
2015

12. Comparison of Pfizer growth with other MNCs
IMPACT OF NLEM 2015
ON PFIZER

13. Cardiac segment
Anti-infective segment Anti-infective segment
Molecule
wise sales
Anti- diabetic segment

14. ACUTE/ CHRONIC BREAK UP

15. PRE-NLEM: Rise the price to harvest maximum profit.
POST-NLEM: If increase in volume will maintain the
profit, then promotion should not be stopped.
Keep the margin same for distributor and retailer to
maintain good relationship with them.
Start focusing on Semi regulated
countries.
Product Line extension.
STRATERGYFORPFIZERANDCIPLA

16. MNC

17. Thank You